Cargando…

Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?

(1) Background: Only 60–70% of depressed patients respond to standard antidepressant treatments. Hence, it is essential to search for new, effective and safe therapies for unmet clinical needs of treatment-resistant depression (TRD). Agents targeting the components of the JAK-STAT signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gałecka, Małgorzata, Szemraj, Janusz, Su, Kuan-Pin, Halaris, Angelos, Maes, Michael, Skiba, Aleksandra, Gałecki, Piotr, Bliźniewska-Kowalska, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999744/ https://www.ncbi.nlm.nih.gov/pubmed/35407663 http://dx.doi.org/10.3390/jcm11072056

Ejemplares similares

Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2022)

Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2020)

CASP3 gene expression and the role of caspase 3 in the pathogenesis of depressive disorders
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2023)

Expression of p11 in Patients with Depression
por: Gałecka, Małgorzata, et al.
Publicado: (2022)

Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders—The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3
por: Gałecka, Małgorzata, et al.
Publicado: (2021)

Update on the neurodevelopmental theory of depression: is there any ‘unconscious code’?
por: Gałecka, Małgorzata, et al.
Publicado: (2020)

Expression of Selected Genes Involved in Neurogenesis in the Etiopathogenesis of Depressive Disorders
por: Bliźniewska-Kowalska, Katarzyna, et al.
Publicado: (2021)

A Review of the Global Impact of the COVID-19 Pandemic on Public Mental Health, with a Comparison Between the USA, Australia, and Poland with Taiwan and Thailand
por: Bliźniewska-Kowalska, Katarzyna M., et al.
Publicado: (2021)

Neuroimmunology and (Epi)Genetics in Depressive Disorders
por: Gałecki, Piotr, et al.
Publicado: (2021)

Ways of Coping with Stress among Patients with Depressive Disorders
por: Orzechowska, Agata, et al.
Publicado: (2022)

Single-Nucleotide Polymorphisms in Genes Maintaining the Stability of Mitochondrial DNA Affect the Occurrence, Onset, Severity and Treatment of Major Depressive Disorder
por: Czarny, Piotr, et al.
Publicado: (2023)

Emotional control in selected somatic and psychiatric diseases
por: Orzechowska, Agata, et al.
Publicado: (2023)

Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study
por: Skiba, Aleksandra, et al.
Publicado: (2021)

Experiencing Violence among Children and Adolescents with Depression in the Aspect of Polish Law
por: Lewandowska, Aleksandra, et al.
Publicado: (2022)

Immune to happiness – inflammatory process indicators and depressive personality traits
por: Talarowska, Monika E., et al.
Publicado: (2019)

Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland
por: Gałecka, Elżbieta, et al.
Publicado: (2012)

Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study
por: Jasionowska, Justyna, et al.
Publicado: (2019)

Inflammatory Markers and Episodic Memory Functioning in Depressive Disorders
por: Wachowska, Katarzyna, et al.
Publicado: (2022)

Oxidant/antioxidant imbalance is an inherent feature of depression
por: Talarowska, Monika, et al.
Publicado: (2015)

Psychiatric Treatment in Pregnancy: A Narrative Review
por: Gruszczyńska-Sińczak, Iga, et al.
Publicado: (2023)

Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression
por: Talarowska, Monika, et al.
Publicado: (2016)

Personality Traits and Inflammation in Depressive Disorders
por: Wachowska, Katarzyna, et al.
Publicado: (2022)

The role of interleukin genes in the course of depression
por: Talarowska, Monika, et al.
Publicado: (2016)

Birth Month and Course of Recurrent Depressive Disorders in a Polish Population
por: Talarowska, Monika, et al.
Publicado: (2018)

Expression and Activity of Metalloproteinases in Depression
por: Bobińska, Kinga, et al.
Publicado: (2016)

Single-Nucleotide Polymorphisms of Genes Involved in Repair of Oxidative DNA Damage and the Risk of Recurrent Depressive Disorder
por: Czarny, Piotr, et al.
Publicado: (2016)

ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder
por: Talarowska, Monika, et al.
Publicado: (2014)

Single-nucleotide polymorphisms of uracil-processing genes affect the occurrence and the onset of recurrent depressive disorder
por: Czarny, Piotr, et al.
Publicado: (2018)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia
por: Broniarczyk-Czarniak, Marta, et al.
Publicado: (2022)

Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder
por: Bialek, Katarzyna, et al.
Publicado: (2020)

Impact of Single Nucleotide Polymorphisms of Base Excision Repair Genes on DNA Damage and Efficiency of DNA Repair in Recurrent Depression Disorder
por: Czarny, Piotr, et al.
Publicado: (2016)

Association between single nucleotide polymorphisms of TPH1 and TPH2 genes, and depressive disorders
por: Wigner, Paulina, et al.
Publicado: (2018)

The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)

Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders
por: Talarowska, Monika, et al.
Publicado: (2014)

The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
por: Thomas, S J, et al.
Publicado: (2015)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
por: Huang, I-Hsin, et al.
Publicado: (2022)

Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
por: Shkundin, Anton, et al.
Publicado: (2023)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
por: Szalus, Krzysztof, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9r9e563d2ag1qj9jk6v1d7mrb